Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 14 - Issue 9 - September 2017

The VIRTUS Feasibility Trial
09/10/2017

Lowell S. Kabnick, MD, RPhS, FACS, FACPh

 

Director, NYU Vein Center, New York, New York.

Lowell S. Kabnick, MD, RPhS, FACS, FA...
Dr Kabnick presents a clinical update on the VIRTUS trial, which is studying the dedicated venous Veniti Vici stent.
Dr Kabnick presents a clinical update on the VIRTUS trial, which is studying the dedicated venous Veniti Vici stent.
Dr Kabnick presents a clinical...
09/10/2017
Vascular Disease Management
Exertional Dyspnea Secondary To Iliac Vein Occlusion, Treated By Recanalization
09/10/2017
Dr Walker presents this month’s case report by Attaran et al, in which iliac vein occlusion was established as the etiology of exertional dyspnea and diminished exercise capacity and where there was symptomatic improvement following iliac...
Dr Walker presents this month’s case report by Attaran et al, in which iliac vein occlusion was established as the etiology of exertional dyspnea and diminished exercise capacity and where there was symptomatic improvement following iliac...
Dr Walker presents this month’s...
09/10/2017
Vascular Disease Management

Column

New Techniques
Occlusion Perfusion Catheter (OPC): A Universal Drug-Delivery Device--Next Generation
09/10/2017

Rex Teeslink, MD1 and Saami K. Yazdani, PhD2

1Inventor/Co-Founder/Scientific Advisor, Advanced Catheter Therapies, Inc.; 2Assistant Professor, Mechanical Engineering Department, University of South Alabama, Mobile, Alabama

Rex Teeslink, MD1 and Saami K. Yazdan...
The authors present the Occlusion Perfusion catheter (OPC), a universal drug-delivery device. This catheter allows for delivery of antiproliferative drug to a targeted treatment area, demonstrates exceptional medial layer drug uptake, and can...
The authors present the Occlusion Perfusion catheter (OPC), a universal drug-delivery device. This catheter allows for delivery of antiproliferative drug to a targeted treatment area, demonstrates exceptional medial layer drug uptake, and can...
The authors present the...
09/10/2017
Vascular Disease Management

Insights

Commentary
Popliteal Artery Entrapment Syndrome
09/10/2017

Sushruth Edla, MD and Thomas P. Davis, MD

 

St. John Hospital and Medical Center, Detroit, Michigan

Sushruth Edla, MD and Thomas P. Davis...
The authors offer their perspective on this month’s article on Popliteal Artery Entrapment Syndrome by Mustapha et al.
The authors offer their perspective on this month’s article on Popliteal Artery Entrapment Syndrome by Mustapha et al.
The authors offer their...
09/10/2017
Vascular Disease Management

Feature

Case Series
Popliteal Artery Entrapment Syndrome: A Case Series With Variable Timing of Diagnosis and Outcome
09/10/2017

Jihad A. Mustapha, MD, Fadi Saab, MD, Kristopher Danielson, DO, Larry J. Diaz-Sandoval, MD, David Bielema, MD, Teresa Hall, DO, Matthew Schuch, MS, Michael Sumners, DO

 

Metro Health – University of Michigan Health, Wyoming, Michigan

Jihad A. Mustapha, MD, Fadi Saab, MD,...
Popliteal artery entrapment syndrome (PAES) is a rare condition that occurs primarily in young active patients. We present a case series that highlights the diagnosis of PAES and represents the variability of outcomes based on timing of...
Popliteal artery entrapment syndrome (PAES) is a rare condition that occurs primarily in young active patients. We present a case series that highlights the diagnosis of PAES and represents the variability of outcomes based on timing of...
Popliteal artery entrapment...
09/10/2017
Vascular Disease Management
Case Report
Exertional Dyspnea Due to Iliac Vein Occlusion, Treated by Recanalization
09/10/2017

Robert Attaran, MD; Sunny Jhamnani MD; Carlos Mena-Hurtado, MD

 

Yale-New Haven Hospital, Yale University, New Haven, Connecticut

Robert Attaran, MD; Sunny Jhamnani MD...
Exertional dyspnea has many causes. We report a case of exertional dyspnea resulting from preload insufficiency due to inadequate venous return.
Exertional dyspnea has many causes. We report a case of exertional dyspnea resulting from preload insufficiency due to inadequate venous return.
Exertional dyspnea has many...
09/10/2017
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

September 2017 Volume 14 Issue 9

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement